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OBJECTIVE: To perform a comparative analysis of the effects of platelet-rich plasma and centrifuged bone marrow
aspirate on the induction of bone healing in rabbits.
METHOD: Twenty adult, male New Zealand rabbits were randomly separated into two equal groups, and surgery
was performed to create a bone defect (a cortical orifice 3.3 mm in diameter) in the proximal metaphysis of each
rabbit’s right tibia. In the first group, platelet-rich plasma was implanted in combination with b-tricalcium
phosphate (platelet-rich plasma group), and in the second group, centrifuged bone marrow in combination with b-
tricalcium phosphate (centrifuged bone marrow group) was implanted. After a period of four weeks, the animals
were euthanized, and the tibias were evaluated using digital radiography, computed tomography, and
histomorphometry.
RESULTS: Seven samples from each group were evaluated. The radiographic evaluation confirmed the absence of
fractures in the postoperative limb and identified whether bone consolidation had occurred. The tomographic
evaluation revealed a greater amount of consolidation and the formation of a greater cortical bone thickness in the
platelet-rich plasma group. The histomorphometry revealed a greater bone density in the platelet-rich plasma
group compared with the centrifuged bone marrow group.
CONCLUSION: After four weeks, the platelet-rich plasma promoted a greater amount of bone consolidation than
the bone marrow aspirate concentrate.
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INTRODUCTION
There is a need for the development of safer, more efficient,
and more effective surgical procedures for the consolidation
of fractures,1 for reconstruction (bone loss) and replacement of
bone segments. There is a large demand due to the increasing
number of victims of accidents and injuries (falls, traffic
accidents, accidents at work, aggressions, and other external
causes of morbidity), and of patients suffering from orthope-
dic diseases (idiopathic, degenerative, metabolic, infectious,
auto-immune, congenital, and neoplastic pathologies).
In Brazil, it is expected a significantly increase in life
expectancy at birth and rapid growth of the elderly
population.2 With this proportional increase in elderly
population and the relative aging of country, it is expected
an elevation in the incidence of fractures due to osteoporo-
sis. This expectation is aggravated by the prospect of
worsening conditions resulting from uncontrolled urban
concentration (an increased occurrence of traffic accidents
and violence). This scenario makes urgent the search for
innovative procedures, practical, and possible to be imple-
mented in the public hospitals in the unified health care
system of Brazil (equity).
Researchers are attempting to gain a better understanding
of the physiology of bone consolidation3 for the develop-
ment of surgical techniques for internal and external
fracture fixation1. In addition, researchers are searching for
the best solutions for possible sequelae and complications,
such as vicious consolidation, delayed consolidation, or the
absence of consolidation (pseudo-arthrosis).4
New resources and technologies are continually being added
to the therapeutic arsenal of orthopedic surgeons. Systemically
administered drugs are currently being evaluated, especially
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medication that is used for the treatment and prevention of
osteoporosis, such as bisphosphonates,5,6 osteoconductive
agents, synthetic and composite (organic/synthetic) bone
substitutes,7 and osteoinductive agents, including platelet-rich
plasma (PRP),8-11 bone marrow concentrate (BMC),12-15 bone
morphogenetic proteins (BMPs),16,17 and gene therapy.18
Devices that provide osteostimulation using pulsed electro-
magnetic fields,19 electric microcurrents,20 and extracorporeal
shockwaves21 are also being evaluated.
The clinical results of synthetic osteoconductive and
osteoinductive materials are still controversial. Autologous
bone (an autograft) that is removed from the ilium is still the
most widely used type of graft and is considered to be the
gold standard of osteoconductive, osteogenic, and osteoin-
ductive agents.22
The use of autografted bone that has been taken from the
ilium or another donor region of the patient is not always
possible or indicated because of the need for a second
surgical procedure, the limitation of the bone stock, and the
possible complications (unaesthetic scarring, pain, risk of
alterations in local sensitivity, and infection).23 In these
cases, synthetic osteoconductive biomaterials [hydroxyapa-
tite, b tricalcium phosphate (bTCP), other phosphates and
carbonates, collagen, composites, and other biomaterials
used as scaffolds or carriers] are viable options, especially
when these materials are used in combination with a
biological autologous osteoinductor, such as platelet-
rich plasma,24 concentrated bone marrow aspirate,25 or
tissue growth factors.17 PRP and centrifuged BMC are the
most commonly used osteoinductors, in combination with
synthetic osteoconductors, due to their convenience, the
technical ease with which they are obtained, intraoperative
processing, lack of immunogenicity, non-transmissibility of
diseases, and low cost.
We sought to evaluate the efficacy of two osteoinductive
agents - platelet-rich plasma and centrifuged bone marrow
aspirate - in conjunction with b tricalcium phosphate, a
commercial synthetic osteoconductive agent. The present
study is a controlled prospective study that used rabbits as
an experimental model to compare the quality of the bone
that was formed in tibial defects. The findings of the present
study allow for the selection of the most effective osteoin-
ductive agent.
METHODS
The research protocol of the present study was prepared
in accordance with Law n˚ 11,794 from October 8, 2008,
which establishes procedures for the scientific use of
animals. The present study was approved by the Ethics
Committee of Londrina State University (UEL) and the
Ethics Commission for the Analysis of Research Projects at
the Hospital das Clinicas, University of Sa˜o Paulo School of
Medicine (FMUSP). This study also followed the procedures
established in the guide of the Canadian Council on Animal
Care26 for the maintenance, management, sedation, analge-
sia, anesthesia, and euthanasia of small animals.
Twenty New Zealand albino, adult male rabbits
(Oryctolagus cuniculus) were used, with a mean weight of
2700 g. The animals, which were clinically healthy and were
obtained from a commercial source, were housed at the
Vivarium of the University Hospital (UH) in Londrina, Parana´.
To evaluate the autologous osteoinductive agents, two
experimental groupswere formed, with ten rabbits randomly
distributed in each group. The first group received platelet-
rich plasma (PRP group), and the second group received
centrifuged bone marrow aspirate (BMC group). The two
types of osteoinductive agents were associated with a
commercial absorbable osteoconductive agent; b tricalcium
phosphate (Cerasorb H M - Curasan AG International -
Kleinostheim, Germany), with a grain size of 500 to 1000 mm,
a porosity of 65%, and a pore size of 5 to 500 mm.
All of the animals were transferred from the rabbit
vivarium to the Surgical Technique Laboratory at the Center
for Health Sciences, UEL. After weighing, the animals were
anesthetized according to the anesthesia protocol for small
animals of the Canadian Council of Animal Care26 (an
intramuscular injection in the proximal region of the left
pelvic limb of a solution containing 40 mg/kg body weight
of 10% dextro-ketamine hydrochloride and 2% 5 mg/kg
body weight of xylazine hydrochloride) and were then
tattooed on the right ear with numbers from 1 to 20.
For the preparation of the platelet-rich plasma, a 9-ml
sample of blood was collected using a cardiac puncture
from the rabbits in the PRP group. The blood sample from
each animal was sent to the Postgraduate Laboratory of
Internal Medicine at the Center for Health Sciences, UEL
and was centrifuged for ten minutes at a speed of 1200 rpm
at room temperature. The fraction that separated from the
PRP was transferred to another sterile tube and was stored.
Next, 0.2 ml of 10% calcium gluconate was added to the
tube with the PRP, and after a few minutes, a clot was
formed (activation of PRP). After these processing steps, the
tube with the activated PRP was returned to the Surgical
Technique Laboratory for use in the surgical procedure.27
Trichotomies were produced in the region of the anterior
tibial tuberosity up to the middle of the leg in both groups of
rabbits and in the right iliac crest region in the animals of the
BMC group. Antisepsis and asepsis were performed with 2%
chlorhexidine gluconate antiseptic and a 0.5% alcoholic
solution of chlorhexidine digluconate, respectively.
To prepare the centrifuged bone marrow aspirate, a 5-ml
sample was collected. A marrow puncture was made in the
right iliac bone of the rabbits in the BMC group, and 5 ml of
bone marrow was aspirated using strong suction with a
heparinized syringe (151000 heparin solution). This material
was immediately sent for processing, in a chilled container,
to the Postgraduate Internal Medicine Laboratory. The bone
marrow sample was transferred to a sterile tube and was
centrifuged at 400 rpm for ten minutes. In the intermediate
fraction that was formed after centrifugation (‘‘buffy-coat’’),
stromal bone marrow cells and hematopoietic precursors
(mesenchymal stem cells and progenitor cells) were
observed. Next, the fraction that was obtained was homo-
genized in a vortex agitator. Trypan blue dye was then
applied to a 50-ml sample in separate Eppendorf tubes to test
the cell viability. The viable cells with intact cytoplasmic
membranes exhibited no basophilia. A sample was con-
sidered viable when the number of stained cells that were
observed using optical microscopy was insignificant.25 After
the verification of the cell viability, a volume of approxi-
mately 0.5 ml of the remaining centrifuged bone marrow
aspirate (BMC) was sent to the Surgical Technique
Laboratory for use in the operation.
Infiltration of a local anesthetic (0.5% bupivacaine hydro-
chloride) without a vasoconstrictor was completed before
the surgical procedures to improve the postoperative
analgesia. For the surgical procedure, each animal was
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positioned in the supine position while under general
anesthesia. A cutaneous access route of 1.5 cm was made
on the anteromedial side of the right leg, over the proximal
tibial metaphyseal region. Next, the soft tissues were moved
to the side, and the periosteum was opened. The exposed
medial metaphyseal-diaphyseal transition region of the
tibia was perforated with a dental trephine that was
3.3 mm in diameter. A dental drill with controlled rotation
(800 rpm) was used to avoid local thermal damage to the
bone tissue.
In the PRP group, the platelet-rich plasma (PRP)
coagulum was deposited over the ß tricalcium phosphate
in a petri dish, forming a cylinder that was inserted into the
bone defect (Figures 1A and 1B).
In the BMC group, the centrifuged bone marrow aspirate
and beta tricalcium phosphate were homogenized. The
resulting paste was introduced into the tibial bone defect.
After completion of the procedures for filling the bone
defects, each animal’s skin was sutured with polyamide
(mononylon) surgical thread, size 3-0. Occlusive dressing
was not used and the limb was not immobilized. Next, the
animals were intramuscularly administered antibiotic med-
ications, penicillin G benzathine, and procaine (Pencivet H
PPU), and the anti-inflammatory drug piroxicam. After
recovery from the anesthesia in their individual transport
cages, each rabbit was taken to the vivarium. Normal
weight bearing on the limbs was allowed in the immediate
postoperative period.
The animals were kept alive for a four-week follow-up
period after the operation, which is a sufficient length of
time for bone healing in rabbits.5,25
The animals were euthanized using an intracardiac lethal
injection with 20% potassium chloride26 under anesthesia by
intramuscular injection of a solution of dextro-ketamine
hydrochloride and xylazine hydrochloride.26 The same
anesthesia was used during the operations and was subject
to resolution No. 714 (2002) of the Federal Council of
Veterinary Medicine and to Law No. 11794 from October 8,
2008.
The rabbit tibias were removed and were dissected from
the soft tissue. These tibias were then immediately packed
in appropriate containers with a 10% buffered formalin
solution and were identified by the animal’s number. The
respective contra-lateral (left) tibias were removed in the
same way and were submitted to bone densitometry to test
for equivalence between the groups.
The results of the bone defect consolidation obtained in
the PRP and BMC groups were compared using digital
radiography, computed tomography, and histology by
histomorphometry.
Digital radiography was used to assess whether con-
solidation had occurred. This technique also verified the
incidence of fractures in each tibia (an exclusion criterion).
The thickness of the newly formed cortical wall was
measured from the volumetric axial acquisition using a
tomographic device with multiple rows of detectors
followed by reconstruction in the planes of the cortical
bone defects (Figures 2A and 2B).
Imaging test evaluations were performed by experienced
radiologists, and in the case of the radiological evaluations,
the evaluations were performed jointly by two radiologists
(by consensus).
After the imaging tests, the right tibias were sent for bone
histomorphometry, were decalcified, washed, and sliced,
and the regions of the bone defects were submitted to
routine histology. Slides with 4-mm-thick histological sec-
tions were stained using hematoxylin-eosin (HE). The
relative formation (%) of bone tissue in each sample was
measured using a ZeissH optical microscope (40X magnifi-
cation) with the aid of an image analyzer.
The frequencies of consolidation of the defects were
compared between the PRP and BMC groups, as
measured by digital radiography, according to Fisher’s
exact test (nominal samples). The normality of the
distributions of the parameters of the thickness of the
newly formed cortical wall (mm), as measured by CT
scan, and of the bone formation (%), as determined by
histomorphometry, were confirmed by Pearson’s coeffi-
cient of variation (PCV,30%) and the Kolmogorov-
Smirnov test (KS: p.0.05). Student’s t-test for two
independent parametric samples was used to compare
the results for cortical wall thickness (mm) and bone
formation (%) of the BMC and PRP groups. A confidence
Figure 1 - Bone defect obtained after drilling in the right tibia (a)
and after implantation of the bTCP and PRP cylinder (b).
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level of 5% was adopted (a = 0.05), and these statistical
tests were two-dimensional.
RESULTS
The results for the defect consolidation, newly formed
cortical wall thickness (mm), and bone formation (%) are
shown in Tables 1, 2, and 3, respectively.
DISCUSSION
Platelet-rich plasma8-11,23,24 and centrifuged bone marrow
aspirate12-15,25 are agents with proven osteoinductive activities
and are often used in orthopedic bone reconstruction surgery.
We compared the effects of platelet-rich plasma and cen-
trifuged bone marrow aspirate combined with a commercial
synthetic osteoconductive material (ß tricalcium phosphate)
on the consolidation of bone defects. Autogenous bone grafts
that use ground cortical-spongy bone are considered to be the
gold standard. These grafts exhibit proven osteoinductive and
osteoconductive properties that overlap with those of the
agents studied22,23 and that would hinder the assessment of
differences between PRP and BMC.
Unlike other reports,28 no blood samples were collected
for the platelet counts in the present study because the
amount of blood available (9 ml) was insufficient. We opted
to carry out only one centrifugation according to the Arenas
protocol.27 One-step centrifugation was sufficient to obtain a
platelet concentration that was approximately six times that
of plasma, which is 320,000 platelets/ml according to the
work of Wilson.28 The platelet concentration obtained with
one centrifugation is approximately 2,000,000 platelets/ml,
which is sufficient for the effects of PRP.27
Figure 2 - Axial CT image of the tibia of an animal in the PRP
group showing the consolidation of newly formed bone defect
and a cortical thickness of 1.3 mm (a) and the BMC group
showing no consolidation of the cortical bone defect (b).
Table 1 - Measurements of the consolidation of defects
filled with PRP+bTCP and BMC+bTCP using radiographic
evaluation. Comparison by Fisher’s exact test (a= 0.05
bilateral).
CONSOLIDATION-
RADIOGRAPHIC
EVALUATION GRAFT MATERIAL
PRP+bTCP BMC+bTCP
n % n %
Consolidation 7 43.8 7 43.8
No consolidation 0 0.0 1 6.2
Fracture1 1 6.2 0 0.0
TOTAL 8 50.0 8 50.0
Fisher p= 1.00
1Tibial fracture, case not included in the statistical analysis.
Table 2 - Cortical thickness (mm) formed after bone
consolidation in defects filled with PRP+bTCP and
BMC+bTCP, measured using computed axial tomography.
Normality assessment using Pearson’s Coefficient of
Variation (PCV) and the Kolmogorov-Smirnov test (KS).
Comparison between grafts using Student’s t-test
(a= 0.05 bilateral).
CORTICAL
THICKNESS (mm) GRAFT MATERIAL
PRP+bTCP BMC+bTCP
M 1.96 1.00
SD 0.36 0.26
SEM 0.13 0.15
MAX 2.3 1.2
MIN 1.3 0.7
N 7 3
PCV (%) 18.39 26.46
KS (p) .0.10 -
Student’s t-test t = 4.10 p= 0.004*
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The tibias of seven rabbits from each group were
evaluated using computed tomography and histomorpho-
metry. In the PRP group, two rabbits died due to
complications during surgery, and another rabbit presented
with a fracture of the tibia. In the BMC group, one animal
was excluded because of a technical problem with the cell
viability test for the sample of centrifuged bone marrow
aspirate, and another was excluded due to self-mutilation
of the operated limb. One case did not present with
consolidation.
The radiographs did not provide quantitative data on
bone consolidation. However, these radiographs provided
a qualitative assessment of the occurrence or the lack of
consolidation. These radiographs also allowed for the con-
firmation of the presence of fractures during the post-
operative period (an exclusion criterion). In the PRP group,
all of the cases presented consolidation. One case was
excluded from the analysis due to the presence of a fracture
of the tibia in the region of the defect. In the BMC group, one
case did not present with consolidation. However, no
statistically significant difference in occurrence of bone
healingwas found between the two groups (p=1.00) (Table 1).
The CT scan proved to be more reliable for confirming the
consolidation of the cortical defects of the tibia, and this scan
also enabled a quantitative assessment of the bone forma-
tion. The thickness of the cortical region of the defect that
formed in the PRP group was found to be greater (p= 0.004)
than that of the BMC group (Table 2).
Histomorphometry of the samples from the PRP group
demonstrated greater relative bone formation per area
(p>0.00) than the samples from the BMC group (Table 3).
In the photographic images that were obtained from the
slides of the BMC group, a lower bone tissue density and a
low regenerated trabecular density were observed (Figure 3).
During the four-week period, the larger amount of
consolidation that was observed in the PRP group than in
the BMC group may be explained by the relative differences
in the factors that were observed in the blood compositions
of these groups. The PRP group presented with significantly
greater amounts of blood platelets and the fundamental
proteins secreted by these platelets, such as platelet-derived
growth factor (PDGF), transforming growth factor b (TGF
b1 and TGF b2), vascular endothelial growth factor (VEGF),
and epithelial growth factor (EGF),28 than the BMC group.
This finding is important because these proteins are needed
to begin the healing process in all tissue types.
PDGF is the first and principal growth factor that is
secreted during any tissue damage, i.e., its action initiates
the process of induction and differentiation of connective
tissue, which culminates in healing of the injury.24
The mesenchymal stem cells of the centrifuged bone
marrow may require a longer period of time for consolida-
tion, similar to that obtained by the platelet-rich plasma
(wall thickness). However, based on the results of the
histomorphometry, it is unlikely that BMC produces the
same quality of bone as PRP because we observed a
significantly greater amount of fibrosis formation in the
interstices of the newly formed bone in the region of the
consolidated defect when BMC was used, and these tissues
would be difficult to replace later.
CONCLUSION
Better consolidation, as indicated by the formation of
thicker cortical walls and a higher relative quantity of bone
tissue per area, was observed in the group that was treated
with platelet-rich plasma and ß tricalcium than in the
Figure 3 - Photomicrographs of bone defect consolidation in an
animal in the PRP group (a) and the BMC group (b).
Table 3 - Bone tissue formed by area (%) after
consolidation of defects filled with PRP+bTCP or
BMC+bTCP, as measured using histomorphometry.
Normality assessment using Pearson’s Coefficient of
Variation (PCV) and the Kolmogorov-Smirnov test (KS).
Comparison using Student’s t-test (a= 0.05 bilateral).
BONE TISSUE FORMED (%) GRAFT MATERIAL
PRP+bTCP BMC+bTCP
M 65.02 36.88
SD 5.71 9.05
SEM 2.16 3.42
MAX 72.13 48.17
MIN 59.07 26.39
N 7 7
PCV (%) 8.78 24.55
KS (p) .0.10 .0.10
Student’s t-test t = 6.96 p>0.00*
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animals that were treated with centrifuged bone marrow
aspirate and ß tricalcium phosphate.
The platelet-rich plasma promoted a more effective
consolidation than the centrifugation of the bone marrow
aspirate.
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